A cross-sectional study on the immunological properties of the cow's milk protein hydrolysates and hydrolyzed formulas using blood samples from children with cow's milk allergy

A cross-sectional study on the immunological properties of the cow's milk protein hydrolysates and hydrolyzed formulas using blood samples from children with cow's milk allergy - A cross-sectional study on the immunological properties of the cow's milk protein hydrolysates and hydrolyzed formulas using blood samples from children with cow's milk allergy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046543

Enrollment

Registered

2022-01-08

Start date

2022-01-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cow&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Children from 2 to- 15 years old 2. Children with cow's milk allergy 3. Children having a history of immediate symptoms by milk components and cow's milk specific IgE level of 3.5 UA/ml or higher 4. Children who have a diet in which milk components are removed 5. Children who do not have any safety problem even if 7 ml of additional blood is collected at the time of normal blood collection

Exclusion criteria

Exclusion criteria: 1. Children who took antihistamine agents within 3 days from the scheduled blood sampling date 2. Children who took the agents that affect the immune system such as steroids within 1 week from the scheduled blood sampling date 3. Children judged to be inappropriate as research subjects by the investigator

Design outcomes

Primary

Measure	Time frame
The reactivities of IgE and basophils to food	—

Countries

Japan

Contacts

Public ContactTakeshi Matsubara

Morinaga Milk Industry Co., Ltd. Health Care & Nutritional Science Institute, R&D Division

ta-matsubara@morinagamilk.co.jp046-252-3057

Outcome results